Japan Industrial Solutions supports troubled local drug maker
Japan Industrial Solutions (JIS) has agreed to invest up to JPY 20bn (USD 155m) in Japan-based generic drug manufacturer Nichi-Iko Pharmaceutical with a view to saving the troubled company.
The private equity firm, which was established by Development Bank of Japan, Mizuho Bank, Sumitomo Mitsui Banking Corporation, and MUFG Bank, will commit capital from its third fund, according to a filing....
More on North Asia
Latest News
India's Innoven fractionalises venture debt fund
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
Australian needle-free vaccine start-up raises $23m
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek, A91, Kae back $135m round for India's HealthKart
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.